Lexicon Pharmaceuticals Inc (LXRX) — Financial Flexibility Index
Lexicon Pharmaceuticals Inc (LXRX) has a Financial Flexibility Index of -0.22x as of March 2026. Free cash flow of $-14.73 Million (operating CF $-14.73 Million minus capex $0.00) represents 0% of total liabilities ($65.96 Million). Check LXRX strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lexicon Pharmaceuticals Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Lexicon Pharmaceuticals Inc across 27 annual periods. See how liquid is Lexicon Pharmaceuticals Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lexicon Pharmaceuticals Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Lexicon Pharmaceuticals Inc. For the full company profile including market capitalisation, see LXRX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.88x | $-67.85 Million | $-67.85 Million | $77.45 Million | ▲ +24.9% |
| 2024 | -1.17x | $-177.75 Million | $-178.78 Million | $152.47 Million | ▲ +1.6% |
| 2023 | -1.18x | $-161.43 Million | $-161.90 Million | $136.32 Million | ▼ -4.4% |
| 2022 | -1.13x | $-87.53 Million | $-88.85 Million | $77.17 Million | ▲ +69.2% |
| 2021 | -3.68x | $-85.80 Million | $-87.02 Million | $23.31 Million | ▼ -22.1% |
| 2020 | -3.01x | $-142.88 Million | $-142.97 Million | $47.42 Million | ▼ -895.5% |
| 2019 | 0.38x | $113.88 Million | $113.81 Million | $300.61 Million | ▲ +179.2% |
| 2018 | -0.48x | $-148.51 Million | $-148.61 Million | $310.54 Million | ▲ +0.7% |
| 2017 | -0.48x | $-185.17 Million | $-185.39 Million | $384.44 Million | ▲ +12.6% |
| 2016 | -0.55x | $-175.40 Million | $-175.63 Million | $318.22 Million | ▼ -209.5% |
| 2015 | 0.50x | $185.69 Million | $184.78 Million | $368.98 Million | ▲ +224.8% |
| 2014 | -0.40x | $-75.54 Million | $-75.62 Million | $187.36 Million | ▲ +53.1% |
| 2013 | -0.86x | $-89.36 Million | $-91.08 Million | $104.00 Million | ▲ +3.9% |
| 2012 | -0.89x | $-93.97 Million | $-94.46 Million | $105.10 Million | ▼ -37.0% |
| 2011 | -0.65x | $-86.73 Million | $-87.94 Million | $132.94 Million | ▲ +3.7% |
| 2010 | -0.68x | $-81.24 Million | $-82.37 Million | $119.86 Million | ▲ +27.9% |
| 2009 | -0.94x | $-88.65 Million | $-89.02 Million | $94.26 Million | ▲ +33.9% |
| 2008 | -1.42x | $-93.41 Million | $-95.60 Million | $65.68 Million | ▼ -62.5% |
| 2007 | -0.88x | $-72.42 Million | $-74.32 Million | $82.72 Million | ▼ -72.0% |
| 2006 | -0.51x | $-53.33 Million | $-56.91 Million | $104.77 Million | ▼ -294.9% |
| 2005 | 0.26x | $34.72 Million | $23.44 Million | $132.91 Million | ▲ +177.6% |
| 2004 | -0.34x | $-30.45 Million | $-42.26 Million | $90.39 Million | ▼ -1274.2% |
| 2003 | -0.02x | $-2.89 Million | $-7.72 Million | $117.98 Million | ▲ +91.3% |
| 2002 | -0.28x | $-9.03 Million | $-28.79 Million | $31.87 Million | ▼ -35.5% |
| 2001 | -0.21x | $-4.52 Million | $-17.99 Million | $21.62 Million | ▼ -144.0% |
| 2000 | 0.48x | $6.21 Million | $-1.50 Million | $13.06 Million | ▲ +221.8% |
| 1999 | -0.39x | $-5.50 Million | $-9.60 Million | $14.10 Million | — |